Literature DB >> 15557517

Severe cardiac arrhythmias in young patients with myotonic dystrophy type 1.

G Bassez1, A Lazarus, I Desguerre, J Varin, P Laforêt, H M Bécane, C Meune, M C Arne-Bes, Z Ounnoughene, H Radvanyi, B Eymard, D Duboc.   

Abstract

Cardiac tachyarrhythmias have rarely been studied in young patients with myotonic dystrophy type 1 (DM1). The authors observed major cardiac rhythm disturbances in 11 patients aged 10 to 18 years. Tachyarrhythmic events were more frequent than impulse conduction disorders. Wide variations in CTG expansion were observed among the population. Since physical exercise was a prominent arrhythmogenic factor, systematic exercise tests with EKG monitoring may be indicated in young patients with DM1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557517     DOI: 10.1212/01.wnl.0000144343.91136.cf

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  21 in total

1.  Towards an integrative approach to the management of myotonic dystrophy type 1.

Authors:  Cynthia Gagnon; Luc Noreau; Richard T Moxley; Luc Laberge; Stéphane Jean; Louis Richer; Michel Perron; Suzanne Veillette; Jean Mathieu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-20       Impact factor: 10.154

Review 2.  Therapeutics development in myotonic dystrophy type 1.

Authors:  Erin Pennock Foff; Mani S Mahadevan
Journal:  Muscle Nerve       Date:  2011-05-23       Impact factor: 3.217

Review 3.  Mechanisms and management of the heart in myotonic dystrophy.

Authors:  Elizabeth M McNally; Dina Sparano
Journal:  Heart       Date:  2011-07       Impact factor: 5.994

4.  Myotonia congenita and myotonic dystrophy: surveillance and management.

Authors:  Allison Conravey; Lenay Santana-Gould
Journal:  Curr Treat Options Neurol       Date:  2010-01       Impact factor: 3.598

5.  Dynamic changes of nuclear RNA foci in proliferating DM1 cells.

Authors:  Guangbin Xia; Tetsuo Ashizawa
Journal:  Histochem Cell Biol       Date:  2015-02-26       Impact factor: 4.304

6.  Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1.

Authors:  Siham Ait Benichou; Dominic Jauvin; Thiéry De Serres-Bérard; Marion Pierre; Karen K Ling; C Frank Bennett; Frank Rigo; Genevieve Gourdon; Mohamed Chahine; Jack Puymirat
Journal:  Gene Ther       Date:  2022-01-25       Impact factor: 5.250

7.  Transient complete atrioventricular block in a preterm neonate with congenital myotonic dystrophy: case report.

Authors:  Hee Na Kim; Young Kuk Cho; Joo Hyun Cho; Eun Mi Yang; Eun Song Song; Young Youn Choi
Journal:  J Korean Med Sci       Date:  2014-05-30       Impact factor: 2.153

Review 8.  Psychiatric and cognitive phenotype in children and adolescents with myotonic dystrophy.

Authors:  Marie Douniol; Aurélia Jacquette; Jean-Marc Guilé; Marie-Laure Tanguy; Nathalie Angeard; Delphine Héron; Monique Plaza; David Cohen
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-06-19       Impact factor: 4.785

Review 9.  Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2.

Authors:  Andrea Romigi; Valentina Franco; Fabio Placidi; Claudio Liguori; Emanuele Rastelli; Giuseppe Vitrani; Diego Centonze; Roberto Massa
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-31       Impact factor: 5.081

Review 10.  The heart and cardiac pacing in Steinert disease.

Authors:  Gerardo Nigro; Andrea Antonio Papa; Luisa Politano
Journal:  Acta Myol       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.